Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes
Diabetes · 01.06.2024 · 73 (6) · 953-963
DOI: 10.2337/db23-0966 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diabetes, online erschienen am 20.03.2024. Verfasst von Yingnan Fan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. Hauptthemen laut MEDLINE: C-Peptide, Diabetes Mellitus, Type 2, Insulin, Insulin Resistance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hong Kong Research Grants Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Normal-weight individuals with usual-onset type 2 diabetes have reduced β-cell function and greater insulin sensitivity compared with their obese counterparts. The relative contribution of β-cell dysfunction and insulin resistance to young-onset type 2 diabetes (YOD) among normal-weight individuals is not well established. In 44 individuals with YOD (24 with normal weight and 20 with obesity) and 24 healthy control individuals with normoglycemia (12 with normal weight and 12 with obesity), we conducted 2-h 12 mmol/L hyperglycemic clamps to measure acute (0–10 min) and steady-state (100–120 min) insulin and C-peptide responses, as well as insulin sensitivity index. Normal-weight individuals with YOD had lower acute insulin response, steady-state insulin and C-peptide responses, and a higher insulin sensitivity index compared with their obese counterparts with YOD. Compared with BMI-matched healthy control individuals, normal-weight individuals with YOD had lower acute and steady-state insulin and C-peptide responses but a similar insulin sensitivity index. The impairment of steady-state β-cell response relative to healthy control individuals was more pronounced in normal-weight versus obese individuals with YOD. In conclusion, normal-weight Chinese with YOD exhibited worse β-cell function but preserved insulin sensitivity relative to obese individuals with YOD and BMI-matched healthy individuals with normoglycemia. The selection of glucose-lowering therapy should account for pathophysiological differences underlying YOD between normal-weight and obese individuals. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
- Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
ORCID-Profile: Andrea O Y Luk
Förderung
- Hong Kong Research Grants Council
Zitieren
APA
Fan, Y., Chow, E., Lim, C. K. P., Hou, Y., Tsoi, S. T. F., Fan, B., Lau, E. S. H., Kong, A. P. S., Ma, R. C. W., Wu, H., Chan, J. C. N., & Luk, A. O. Y. (2024). Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes. Diabetes, 73(6), 953-963. https://doi.org/10.2337/db23-0966
Vancouver
Fan Y, Chow E, Lim CKP, Hou Y, Tsoi STF, Fan B, et al. Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes. Diabetes. 2024;73(6):953-963. doi:10.2337/db23-0966
BibTeX
@article{Fan2024,
author = {Fan, Yingnan and Chow, Elaine and Lim, Cadmon K P and Hou, Yong and Tsoi, Sandra T F and Fan, Baoqi and Lau, Eric S H and Kong, Alice P S and Ma, Ronald C W and Wu, Hongjiang and Chan, Juliana C N and Luk, Andrea O Y},
title = {Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes},
journal = {Diabetes},
year = {2024},
volume = {73},
number = {6},
pages = {953--963},
doi = {10.2337/db23-0966}
}
EUVIMED